Total Visits

Views
The FDA‐Approved Antiviral Raltegravir Inhibits Fascin1‐Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo55

Total Visits Per Month

January 2024February 2024March 2024April 2024May 2024June 2024July 2024
The FDA‐Approved Antiviral Raltegravir Inhibits Fascin1‐Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo13751010100

File Visits

Views
2021 RAL cancers.pdf19

Top country views

Views
United States18
United Kingdom14
Ireland11
Germany7
South Korea4
Spain1

Top cities views

Views
London14
Dublin11
Frankfurt am Main7
Seoul4
Chicago2
Dallas1
Forest1
Mula1